XLO Return on Tangible Equity | Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. (XLO) Return on Tangible Equity

2026-06-30: Return Tang Equity -30.21%.
2026-03-31: Return Tang Equity -43.15%.
2025-12-31: Return Tang Equity -99.33%.
2025-09-30: Return Tang Equity 722.53%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-30.21%
2026-03-31	-43.15%
2025-12-31	-99.33%
2025-09-30	722.53%
2025-06-30	-795.33%
2025-03-31	-507.50%
2024-12-31	-330.95%
2024-09-30	-299.43%
2024-06-30	-196.11%
2024-03-31	-275.42%
2023-12-31	-207.47%
2023-09-30	-154.70%
2023-06-30	-125.05%
2023-03-31	-105.57%
2022-12-31	-83.51%
2022-09-30	-67.66%
2022-06-30	-56.80%
2022-03-31	-48.45%
2021-12-31	-40.88%
2021-09-30	56.33%
2021-06-30	62.19%
2021-03-31	64.32%
2020-12-31	66.30%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-99.33%
2024-12-31	-330.95%
2023-12-31	-207.47%
2022-12-31	-83.51%
2021-12-31	-40.88%
2020-12-31	66.30%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Serina Therapeutics, Inc. (SER)	United States	$0.054B	-2.35
Clene Inc. (CLNN)	United States	$0.054B	-1.99
HERON THERAPEUTICS, INC. /DE/ (HRTX)	United States	$0.055B	-2.38
Elicio Therapeutics, Inc. (ELTX)	United States	$0.049B
Lite Strategy, Inc. (LITS)	United States	$0.049B
Dogwood Therapeutics, Inc. (DWTX)	United States	$0.049B
Annovis Bio, Inc. (ANVS)	United States	$0.056B	-1.58
Werewolf Therapeutics, Inc. (HOWL)	United States	$0.047B
NOMAD POWER SOLUTIONS, INC. (NMAD)	United States	$0.058B
Grace Therapeutics, Inc. (GRCE)		$0.046B	-1.83